Skip to main content

Advertisement

Table 4 Persistence with initial treatment in different studies

From: Blood pressure reduction, persistence and costs in the evaluation of antihypertensive drug treatment – a review

  Duration ARBs ACEi CCBs BBs Diuretics
Bloom[15] 12 64% 58%*** 50% 43% 38%
Conlin[18] 48 50.9% 46.5% 40.7%** 34.7%** 16.4%**
Hasford[36] 12 51.3% 42.0% 43.6% 49.7% 34.4%
Degli-Esposti[23] 12 41.7% 32.2% 26.7% 36.9% 25.9%
Erkens[37] 12 62.0% 59.7% 34.7% 35.0% 33.0%
Veronesi[19] 24 68.5% 64.5% 51.6%** 44.8%** 34.4%*
Hasford[17] 12 26.4% 28.2% 25.9% 25.8% 21.9%
Patel[16] 12 51.9% 48.0% 38.3% 40.3% 29.9%
  1. Duration is given in month. *p < 0.01; **p < 0.05; *** p < 0.007 vs. ACEi